4
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Enzyme-linked immunosorbent assay (ELISA) for the measurement of small quantities of α2-macroglobulin

, &
Pages 735-740 | Received 28 May 1985, Accepted 24 Jun 1985, Published online: 08 Jul 2009

References

  • Parisi A F, Vallee B L. Isolation of a zinc α2M from human serum. Biochemistry 1970; 9: 2421–6
  • Barrett A J, Starkey P M. The interaction of α2M with proteinases. Characteristics and specificity of the reaction and a hypothesis concerning its molecular mechanism. Biochem J 1973; 133: 709–24
  • Laurell C B, Jeppson J-O. Protease inhibitors in plasma. The Plasma Proteins, Function and the Genetic Control. 2nd edition, F WP Putman. Academic Press, New York 1975; Vol. 1: 229–264
  • Koj A. Comparison of the synthesis and secretion of plasma albumin, fibrinogen and a α2-macroglobulin by slices of Morris hepatomas and rat liver. Br J Exp Path 1980; 61: 332–38
  • Gliemann J, Larsen T R, Sottrup-Jensen L. Cell association and degradation of α2Macroglobulin-Trypsin complexes in hepatocytes and adipocytes. Biochim Biophys Acta 1983; 756: 230–37
  • Hovi T, Mosher D F, Vaheri A. Cultured human monocytes synthesize and secrete α2-macroglobulin. J Exp Med 1977; 145: 1580–89
  • White R, Janoff A, Godfrey H P. Secretion of α2 -macroglobulin by human alveolar macrophages. Lung 1980; 158: 9–14
  • Van Leuven F, Cassiman J J, van den Berge H. Uptage and degradation of α2-macroglobulin-protease complexes in human cells in culture. Exp Cell Res 1978; 117: 273–82
  • Ohlsson K. Interactions in vitro and in vivo between dog trypsin and dog plasma protease inhibitors. Scand J Clin Lab Invest 1971a; 28: 219–23
  • Böm N, Shah I, Totovic V, Karitzky D. Combined α1-antitrypsin and α2-macroglobulin deficiency syndrome. Light microscopic evidence of collagenolytic, lastolytic and myolytic tissue lesions. Path Res Pract 1980; 168: 17–35
  • Müllertz S. Role of α2-macroglobulin as an inhibitor of fibronolysis. The Physiological Inhibitors of Coagulation and Fibrinolysis, D Collen, B Wiman, M P Vertraiti. Elsevier/North Holland and Biomedical Press, New York 1979; 243–45
  • Harpel P C. α2-plasmin inhibitor and α2-macroglobulin-plasmin complexes in plasma. Quantitation by enzyma-like differential antibody immunosorbant assay. J Clin Invest 1981; 68: 46–55
  • Sakamoto W. Immunochemical study of B-glucuronidase inhibitor from porcine sublingual gland. Interaction of B-glucuronidase inhibitor with α2-macroglobulin. Biochem Biophys Acta 1975; 411: 195–201
  • Stollar B D, Rezuke W. Separation of antihistone antibodies from non-immune histone precipitating serum proteins, predominantly α2-macroglobulin. Arch Biochem Biophys 1978; 190: 398–404
  • James K. α2-macroglobulin and its possible role in immune systems. Trends Bil Sci 1980; 5(2)43–47
  • Teodurescu M. Characterization and role in autoimmune diseases of the polyclonal B-cell activator produced by T-cells—the helper factor. Immuno-logical Rev 1981; 55: 156–178
  • Goutner A, Simmler M C, Tapon J, Rosenfeld C. Modulation by α2-macroglobulin of human lymphocyte proliferation in responses to mitogens and antigen. Differentiation 1976; 5: 171–173
  • Tauris P, Andersen P, Christiansen S E. Plaque-forming cell capacity in the senescent. Immunology Lett 1985; 9: 3–8
  • Sottrup-Jensen L, Petersen T E, Magnusson S. A thiol ester in α2-macroglobulin cleaved during proteinase complex formation. FEBS Lett 1980; 121: 275–79
  • James K, Johnson G, Fudenberg H H. The quantitative estimation of α2-macroglobulin in normal, pathological and cord sera. Clin Chim Acta 1966; 14: 207–214
  • Ganrot P O, Schersten B. Serum α2-macroglobulin concentration and its variation with age and sex. Clin Chim Acta 1967; 15: 113–120
  • Barrett A J, Brown M A, Sayers C A. The elec-trophoretically ‘slow’ and ‘fast’ forms of the α2-macroglobulin molecule. Biochem J 1979; 181: 401–418

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.